Ignaty Leshchiner - Concepedia

Author

Ignaty Leshchiner

Also Known As

Chris Lawerenz, Christopher M. Heaphy, Conrad R. Leonard, Daniel A. Leongamornlert, Dave Larson, Dido Lenze, Gupta, Manaswi, Hans Lehrach, Henry Lee-Six, I. D. Leshchiner

310

Publications

35.7K

Citations

H-Index

108

Concepts

All Affiliations

Harvard University Broad Institute Massachusetts General Hospital Dana-Farber Cancer Institute Brigham and Women's Hospital

About

Ignaty Leshchiner is an author at Harvard University specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	29	13.1K
2	Engineering	9	9	467
3	Health Sciences	3	3	1.6K
4	Public Health	2	2	179
5	Natural Sciences	1	1	23

Ignaty Leshchiner

Publications

22.4K

Citations

H-Index

Page 1

	Year	Citations
The Molecular Taxonomy of Primary Prostate Cancer Adam Abeshouse, Jaeil Ahn, Rehan Akbani, Cell UrologyGenitourinary CancerMedicinePathologyPrimary Prostate Cancer	2015	3.1K
Pan-cancer analysis of whole genomes Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Nature	2020	3.1K
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma Benjamin J. Raphael, Ralph H. Hruban, Andrew J. Aguirre, Cancer Cell Functional GenomicsPancreatic CancerPathologyCancer GenomicsPancreatic Ductal Adenocarcinoma	2017	2K
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes Bjoern Chapuy, Chip Stewart, Andrew Dunford, Nature Medicine Hematological MalignancyLymphoid NeoplasiaMolecular SubtypesImmunologyPathology	2018	1.9K
Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in <i>ALK</i> -Rearranged Lung Cancer Justin F. Gainor, Leila Dardaei, Satoshi Yoda, Cancer Discovery	2016	1.1K
The evolutionary history of 2,658 cancers Moritz Gerstung, Clemency Jolly, Ignaty Leshchiner, Nature	2020	1.1K
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors Viktor A. Adalsteinsson, Gavin Ha, Samuel S. Freeman, Nature Communications Metastatic TumorsPathologyTumor BiologyTumor HeterogeneityScalable Whole-exome Sequencing	2017	1K
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma Lauren Fishbein, Ignaty Leshchiner, Vonn Walter, Cancer Cell MedicineComprehensive Molecular CharacterizationPathologyAdrenal DiseaseMolecular Diagnostics	2017	750
Polyclonal Secondary <i>FGFR2</i> Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma Lipika Goyal, Supriya K. Saha, Leah Y. Liu, Cancer Discovery	2016	527
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes Stefan C. Dentro, Ignaty Leshchiner, Kerstin Haase, Cell	2021	520

Page 1